Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Consensus on the use of artificial intelligence in the management and measurement of vestibular schwannomas: A protocol for a modified delphi consensus.

Neuroradiology·2026

Same author

Performance Results and Timing of Cochlear Implantation in Patients With DFNA9 (p.Pro51Ser).

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026

Same author

Trade-offs in proton and photon radiotherapy for pituitary adenomas.

Physics and imaging in radiation oncology·2026

Same author

Pseudoprogression in Koos grade 4 vestibular schwannomas following stereotactic radiosurgery: temporal dynamics and radiological predictors.

Journal of neuro-oncology·2026

Same author

Machine learning in automatic detection of chordoma signature, postoperative residuals, and prognosis of skull base chordomas.

NPJ precision oncology·2026

Same author

Prognostic factors and survival after recurrence in major salivary gland carcinomas: a multicenter study.

Oral oncology·2026

Same journal

Cost-Effectiveness of Perioperative Pembrolizumab in Locally Advanced Head and Neck Cancer.

JAMA otolaryngology-- head & neck surgery·2026

Same journal

Blood Manganese and Risk of Squamous Cell Carcinomas of the Head and Neck.

JAMA otolaryngology-- head & neck surgery·2026

Same journal

Comparison of Diet and Lifestyle Program With 3 Medication Approaches for Laryngopharyngeal Reflux Disease Management.

JAMA otolaryngology-- head & neck surgery·2026

Same journal

International Trends in Head and Neck Cancer Mortality.

JAMA otolaryngology-- head & neck surgery·2026

Same journal

Dynamic Quality-of-Life Trajectories After Head and Neck Reconstruction.

JAMA otolaryngology-- head & neck surgery·2026

Same journal

Smell and Taste Disturbances Among Glucagon-Like Peptide-1 Receptor Agonist Users.

JAMA otolaryngology-- head & neck surgery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 8, 2025

A Unified Methodological Framework for Vestibular Schwannoma Research

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

Radiotherapy for Growing Vestibular Schwannomas.

Mantegh Sethi¹, Shravan Gowrishankar², James Tysome²

¹Department of Otolaryngology, University Hospitals Birmingham, Birmingham, England.

JAMA Otolaryngology-- Head & Neck Surgery

|September 4, 2025

Summary

This summary is machine-generated.

Radiotherapy achieved a 10-year tumor control rate of 76.1% in growing vestibular schwannomas (VS). This study provides crucial data for managing this specific patient group, informing expectations and future research.

More Related Videos

Primary Culture of Human Vestibular Schwannomas

Primary Culture of Human Vestibular Schwannomas

Published on: July 20, 2014

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Experiment Videos

Last Updated: Sep 8, 2025

A Unified Methodological Framework for Vestibular Schwannoma Research

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

Primary Culture of Human Vestibular Schwannomas

Primary Culture of Human Vestibular Schwannomas

Published on: July 20, 2014

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Area of Science:

Neurosurgery
Radiation Oncology
Oncology

Background:

Vestibular schwannomas (VS) are tumors that grow over time.
Limited data exists on radiotherapy outcomes for actively growing VS.
There is a need for specific data on tumor control rates in this growing VS population.

Purpose of the Study:

To estimate tumor control rates in radiologically growing vestibular schwannomas (VS) treated with first-line radiotherapy.
To provide data for a rarely studied subgroup of VS patients.
To inform treatment expectations and guide future research in growing VS.

Main Methods:

International, multicenter cohort study of growing unilateral VS treated with first-line radiotherapy (2000-2023).
Prospectively collected data from 8 tertiary referral skull base units.
Kaplan-Meier analysis used to estimate tumor control rates based on predefined growth criteria.

Main Results:

1883 patients with growing VS were included.
The 10-year tumor control rate was 76.1% using the primary definition (≥3 mm growth within 2 years, then ≥2 mm).
Tumor size and location did not significantly impact treatment failure.

Conclusions:

First-line radiotherapy demonstrates significant tumor control in growing vestibular schwannomas.
The study provides specific outcomes for this distinct VS subgroup.
Findings support radiotherapy as an effective treatment option for growing VS, offering valuable insights for patient management.